Biogen, Inc. (NQ: BIIB )
270.28 USD -3.56 (-1.30%) Official Closing Price Updated: 5:19 PM EST, Jan 20, 2021 Add to My Watchlist
Stories about Biogen, Inc.
Benzinga's Weekend M&A Chatter
June 05, 2016
The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday June 3 through Sunday June 5, ...
4 Takeover Stocks To Buy This Summer
June 05, 2016
Biotech has gone a real tear over the past three weeks after making several “false starts” over the past several months as it emerges from an immense bear market that began late in July of last year....
10 Great Stocks That Will Make a Splash This Summer
June 03, 2016
Biogen Says EU Medicines Agency Accepted Its Investigational Alzheimer's Disease Treatment Aducanumab
June 01, 2016
Biogen Inc. (NASDAQ: BIIB) revealed that aducanumab, its investigational treatment for early Alzheimer's disease (AD), was ...
* Biogen's Investigational Alzheimer's Disease Treatment Aducanumab Accepted Into European Medicines Agency's Prime Program
10 Biotech Stocks With Symptoms of Strong Growth
May 31, 2016
Nasdaq 100 Movers: CHTR, BIIB
May 31, 2016
In early trading on Tuesday, shares of Biogen (BIIB) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.7%. Year to date, Biogen has lost about 5.2% of its...
Biogen Inc (NASDAQ: BIIB) revealed Tuesday that the Committee of Medicinal Products for Human Use (CHMP) of the European Medicines ...
May 27 (Reuters) - The U.S. Food and Drug Administration on Friday approved a once-monthly injection for multiple sclerosis from Biogen Inc and AbbVie Inc, with a boxed warning.
May 27 (Reuters) - The U.S. Food and Drug Administration on Friday approved a once-monthly injection for multiple sclerosis from Biogen Inc and AbbVie Inc.
* Zinbryta has a boxed warning & is available only through a restricted distribution program under a risk evaluation and mitigation strategy
Notable Friday Option Activity: BIIB, SEMG, LGF
May 27, 2016
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Biogen Inc (BIIB), where a total of 6,441 contracts have traded so far, representing...
Radio frequencies frequently emitted by cellphones can cause cancer, according to partial findings of a government study on rats, ...
Bullish Two Hundred Day Moving Average Cross - BIIB
May 26, 2016
In trading on Thursday, shares of Biogen Inc (BIIB) crossed above their 200 day moving average of $280.19, changing hands as high as $284.28 per share. Biogen Inc shares are currently trading up about...
A broad rally today surprised many traders. Technology was a leader up 2% followed by healthcare up 1.49%. US new single family home sales hit an 8 year high a sign of growing prospects for the...
Noteworthy Thursday Option Activity: AHP, WDAY, BIIB
May 19, 2016
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Ashford Hospitality Prime Inc (AHP), where a total volume of 1,023 contracts has...
Noteworthy ETF Outflows: IVW, MO, PCLN, BIIB
May 19, 2016
Symbols mentioned in this story: IVW, MO, PCLN, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Has A Biotech Recovery Started Yet?
May 17, 2016
After a brutal winter, is a warm summer coming for biotech? Citi’s Robyn Karnauskas and Vice President Mohit Bansal asked in a ...
* Regenxbio and Biogen enter exclusive license agreement for the development of gene therapy treatments for rare genetic vision disorders
Notable ETF Outflow Detected - IWB, LLY, TWX, BIIB
May 10, 2016
Symbols mentioned in this story: IWB, LLY, TWX, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Analysts Forecast 12% Upside For The Holdings of OEF
May 09, 2016
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Two of our four top stocks large cap picks Abbvie and Bristol-Myers Squibb are up since we recommended them because of their growth potential in “Immuno-Oncology”.
The Next Sector Rotation Will Be To Biotechs
May 03, 2016
A sector rotation is common, particularly in times of market volatility. However, picking the timing and the right sector is always a ...